Contractors / Astrazeneca Pharmaceuticals LP
Astrazeneca Pharmaceuticals LP
prime recipient of federal awards · UEI E5K2ZJ8CTJH4 ✓ from source
$495.7M
obligated · FY2020
3
funding agencies
94%
from Health and Hum…
0%
single-source
1
states
83%
in Delaware
2
industries
≈ computedSingle-source: 0% of this recipient’s $443.2M in federal contracts was awarded without competition (FPDS extent-competed codes); the rest was competed or unclassified. A high share often reflects sole-source or specialized work, not wrongdoing.
Obligations by year
≈ computed$495.7M
FY20
$502.1M
FY21
$590.7M
FY22
▲ 19%
since FY20
Where this money comes from
✓ from sourceFUNDING AGENCIES
ASTRAZENECA PHARMACEUTIC
HHS
$0.5B
2 other agencies
$0B
Astrazeneca Pharmaceuticals LP
$0.5B
FY2020 obligated
Biggest awards (total value)
awarded 2020$1.1B
Total value over each award’s life, for awards active in FY2020: a decades-long contract can exceed one year’s obligations above.
What it does (NAICS / PSC)
Where the work lands
Delaware✓ from source$413.2M
Competitors
No competitors computed.
Corporate family
Single registration: no combined family.
🔎
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are ✓ from source; figures we calculate are ≈ computed; links we infer (corporate parents, districts, competitors, connections between records) are ≈ inferred, worded carefully, never asserted as fact and never a claim that one thing caused another. Spot an error? Tell us.